IP Library › Assignment 057305/0901
Patent Assignment
Reel/Frame 057305/0901

Assignment of Assignor's Interest

Recorded: 2021-08-27 Pages: 9
Assignors
ROSCIGNO, ROBERT FRANK
Executed: 2018-01-03
FARRER, BRIAN T.
Executed: 2018-01-03
SPRAGUE, JACOB J.
Executed: 2018-01-03
MAYNOR, BENJAMIN
Executed: 2018-01-03
Assignee
LIQUIDIA TECHNOLOGIES, INC.
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NORTH CAROLINA, 27560
Covered Properties (4)
Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension
Application: 16/099,135 →
Publication: US 2019/0151332
Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension
Application: 17/104,348 →
Publication: US 2021/0077504
Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension
Application: 17/390,476 →
Publication: US 2021/0353640
Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension
Application: 17/390,514 →
Publication: US 2021/0353641
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Feb 9, 2023
From: LIQUIDIA TECHNOLOGIES, INC.
To: HCR COLLATERAL MANAGEMENT, LLC
Reel/Frame 062643/0791 →
Assignment of Ip Security Agreement Recorded at Reel/Frame 062643/0791 May 11, 2023
From: HCR COLLATERAL MANAGEMENT, LLC, AS RETIRING SUBORDINATED LENDER
To: HEALTHCARE ROYALTY PARTNERS IV, L.P., AS SUCCESSOR SUBORDINATED LENDER
Reel/Frame 063627/0307 →